top of page
< Back

PolygenRx Announces Collaborative Agreement with Atherion Bioresearch Inc.

​

15 July 2023

PolygenRx will bring its pharmagenic enrichment platform to the suite of clinical trial services offered by Atherion

!
Widget Didn’t Load
Check your internet and refresh this page.
If that doesn’t work, contact us.

PolygenRx

contact@polygenrx.com

Newcastle, NSW, Australia

​

Keywords: PolygenRx; precision medicine; companion diagnostics; targeted therapy; polygenic architecture; drug development, drug discovery; drug repurposing; pharmaceuticals; chronic disease; genetics; pharmagenic enrichment score (PES).

© 2022 PolygenRX

Website design and development by Rosalie Grierson-Burgess

Privacy Policy

Connect With Us On:

  • LinkedIn
  • Twitter
bottom of page